With the opening and construction of several new facilities, 2022 was a banner year for the University of Miami Leonard M. Miller School of Medicine and UHealth – University of Miami Health System. New locations will expand UHealth’s reach to serve more of South Florida’s communities and improve access to world-class academic-based health care, part of the University’s larger strategy to offer health care closer to patients.
In September, UHealth launched a satellite location to care for patients in Doral. The opening marked the first phase of a two-phase project, which will culminate in 2024 with a six-story, 150,000-square-foot multidisciplinary UHealth facility modeled after the health system’s flagship Lennar Foundation Medical Center in Coral Gables.
Phase One of the Doral project, now open, includes an 18,000-square-foot facility at 8333 Northwest 53rd Street in Downtown Doral. The site currently offers services in urology from the Desai Sethi Urology Institute’s specialists and a broad array of cancer services from Sylvester Comprehensive Cancer Center, the region’s only NCI-designated and nationally ranked cancer center and South Florida’s only academic cancer center.
Phase Two of the project will be the state-of-the-art UHealth at Doral facility, being built inside the mixed-use development of Downtown Doral. Slated to open in late 2024, UHealth at Doral will offer a wide range of health care services in addition to oncology and urology, including primary care, cardiology, neurology, and ophthalmology through the No. 1-ranked Bascom Palmer Eye Institute.
Also in September, UHealth broke ground on a world-class medical center at SoLé Mia, the 184-acre mixed-use development in North Miami, a joint venture between real estate developers LeFrak and Turnberry. When completed in early 2025, UHealth at SoLé Mia will be the health system’s largest ambulatory site to date.
The seven-story, 363,000-square-foot medical center will offer the communities of North Miami, Aventura, and the surrounding areas access to academic medicine focused on healing, wellness, and prevention.
The medical center will include cancer specialists from Sylvester; advanced vision care from Bascom Palmer; urological treatments from the Desai Sethi Urology Institute; top-notch care from UHealth’s nationally ranked neurology and neurosurgery programs; and specialties such as cardiology, endocrinology, otolaryngology, gastroenterology, dermatology, physical rehabilitation, and others.
Desai Sethi Urology Institute
In a major step toward becoming a global leader in urology, the Miller School officially dedicated the Desai Sethi Urology Institute in February. The new institute, which was established with a $20 million commitment from the Desai Sethi Family Foundation, is housed in the newly named Desai Sethi Medical Center building at 1150 NW 14th Street on the Miller School campus.
The Desai Sethi Urology Institute will be a beacon for urologic care, attracting top talent, accelerating innovative approaches, and fostering collaboration between specialties such as basic and translational sciences, biomedical engineering, and technology.
Transformational Cancer Research Building
In a bold move to accelerate cancer research, Sylvester Comprehensive Cancer Center broke ground in June on the 244,000-square-foot, state-of-the-art Transformational Cancer Research Building (TCRB). Slated to open in 2024, the 12-story facility on the Miller School campus will be a unique hub for cancer research, innovation, wellness, and patient-centered care.
The TCRB, being built at 1425 NW 10th Ave., will be an ultramodern patient care and research facility to support new and emerging directions in cancer treatment.
The new facility will focus on total-body wellness during cancer treatment to improve quality of life. It will set the standard for survivorship programs that prioritize recurrence prevention for the benefit of patients and their families. The goal is to leverage technology, outstanding researchers, and multidisciplinary collaboration to create a central location for cancer care innovation.